DK3967702T3 - Krystallisering af smac-mimic anvendt som iap-inhibitor og fremgangsmåde til fremstilling deraf - Google Patents
Krystallisering af smac-mimic anvendt som iap-inhibitor og fremgangsmåde til fremstilling deraf Download PDFInfo
- Publication number
- DK3967702T3 DK3967702T3 DK20805780.2T DK20805780T DK3967702T3 DK 3967702 T3 DK3967702 T3 DK 3967702T3 DK 20805780 T DK20805780 T DK 20805780T DK 3967702 T3 DK3967702 T3 DK 3967702T3
- Authority
- DK
- Denmark
- Prior art keywords
- smac
- crystallization
- procedure
- manufacture
- iap inhibitor
- Prior art date
Links
- 238000002425 crystallisation Methods 0.000 title 1
- 230000008025 crystallization Effects 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910389970 | 2019-05-10 | ||
| PCT/CN2020/089437 WO2020228642A1 (zh) | 2019-05-10 | 2020-05-09 | 一种用作iap抑制剂的smac模拟物的结晶及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3967702T3 true DK3967702T3 (da) | 2024-04-15 |
Family
ID=73290153
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK20805780.2T DK3967702T3 (da) | 2019-05-10 | 2020-05-09 | Krystallisering af smac-mimic anvendt som iap-inhibitor og fremgangsmåde til fremstilling deraf |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20220177453A1 (da) |
| EP (1) | EP3967702B1 (da) |
| JP (1) | JP2022531794A (da) |
| KR (1) | KR20220006611A (da) |
| CN (1) | CN113748119B (da) |
| AU (1) | AU2020274768A1 (da) |
| BR (1) | BR112021022509A2 (da) |
| CA (1) | CA3138411A1 (da) |
| DK (1) | DK3967702T3 (da) |
| FI (1) | FI3967702T3 (da) |
| MX (1) | MX2021013729A (da) |
| PT (1) | PT3967702T (da) |
| WO (1) | WO2020228642A1 (da) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101035802A (zh) * | 2004-07-02 | 2007-09-12 | 健泰科生物技术公司 | Iap抑制剂 |
| KR20120127754A (ko) * | 2004-12-20 | 2012-11-23 | 제넨테크, 인크. | Ｉａｐ의 피롤리딘 억제제 |
| JP5452223B2 (ja) * | 2006-07-24 | 2014-03-26 | テトラロジック ファーマシューティカルズ コーポレーション | Ｉａｐ阻害剤 |
| CA2666112A1 (en) * | 2006-10-12 | 2008-04-17 | Novartis Ag | Pyrrolydine derivatives as iap inhibitors |
| CN101605786A (zh) * | 2006-12-19 | 2009-12-16 | 健泰科生物技术公司 | 细胞凋亡抑制剂的咪唑并吡啶抑制剂 |
| AU2009206588A1 (en) * | 2008-01-24 | 2009-07-30 | Tetralogic Pharmaceuticals Corporation | IAP inhibitors |
| WO2019091492A1 (zh) * | 2017-11-13 | 2019-05-16 | 南京明德新药研发股份有限公司 | 用作iap抑制剂的smac模拟物及其用途 |
-
2020
- 2020-05-09 DK DK20805780.2T patent/DK3967702T3/da active
- 2020-05-09 JP JP2021566285A patent/JP2022531794A/ja active Pending
- 2020-05-09 US US17/594,737 patent/US20220177453A1/en active Pending
- 2020-05-09 KR KR1020217040412A patent/KR20220006611A/ko active Search and Examination
- 2020-05-09 WO PCT/CN2020/089437 patent/WO2020228642A1/zh unknown
- 2020-05-09 AU AU2020274768A patent/AU2020274768A1/en active Pending
- 2020-05-09 MX MX2021013729A patent/MX2021013729A/es unknown
- 2020-05-09 CA CA3138411A patent/CA3138411A1/en active Pending
- 2020-05-09 BR BR112021022509A patent/BR112021022509A2/pt unknown
- 2020-05-09 CN CN202080030342.1A patent/CN113748119B/zh active Active
- 2020-05-09 FI FIEP20805780.2T patent/FI3967702T3/fi active
- 2020-05-09 EP EP20805780.2A patent/EP3967702B1/en active Active
- 2020-05-09 PT PT208057802T patent/PT3967702T/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020228642A9 (zh) | 2021-10-21 |
| MX2021013729A (es) | 2021-12-10 |
| WO2020228642A1 (zh) | 2020-11-19 |
| EP3967702A1 (en) | 2022-03-16 |
| JP2022531794A (ja) | 2022-07-11 |
| EP3967702A4 (en) | 2023-01-11 |
| PT3967702T (pt) | 2024-04-09 |
| EP3967702B1 (en) | 2024-03-20 |
| US20220177453A1 (en) | 2022-06-09 |
| FI3967702T3 (fi) | 2024-04-16 |
| CA3138411A1 (en) | 2020-11-19 |
| CN113748119A (zh) | 2021-12-03 |
| BR112021022509A2 (pt) | 2021-12-28 |
| KR20220006611A (ko) | 2022-01-17 |
| CN113748119B (zh) | 2024-04-02 |
| AU2020274768A1 (en) | 2022-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3442973T3 (da) | Hidtil ukendte forbindelser som autotaxinhæmmere og farmaceutiske sammensætninger omfattende samme | |
| DK3761980T3 (da) | Aminosyreforbindelser og fremgangsmåder til anvendelse | |
| DK3661921T3 (da) | Selektive hæmmere af nlrp3-inflammasom | |
| DK3555070T3 (da) | Aminsubstituerede, heterocykliske forbindelser som ehmt2-hæmmere og fremgangsmåder til anvendelse deraf | |
| DK3341355T3 (da) | (s)-3-amino-4-(difluormethylenyl)cyclopent-1-en-1-carboxylsyre og tilhørende forbindelser som gaba-aminotransferaseinaktivatorer til behandling af epilepsi, afhængighed og hepatocellulært karcinom | |
| DK3597369T3 (da) | Fremgangsmåde til dokumenteret tilspænding eller eftertilspænding af en skrueforbindelse | |
| DK3393655T3 (da) | Fenfluramin-sammensætninger og fremgangsmåder til fremstilling af samme | |
| DK3350163T3 (da) | Mono- eller disubstituerede indolderivater som hæmmere af denguevirusreplikation | |
| DK3574135T3 (da) | Fremgangsmåde og formulering til fremstilling af ligninfibre | |
| DK3355329T3 (da) | Metode til fremstilling af lithium-ion-kondensator og kondensator som opnås med den nævnte metode | |
| DK3313833T3 (da) | Forbindelser og anvendelse deraf som inhibitorer af n-myristoyl-transferase | |
| DK3606929T3 (da) | Beta-nicotinat-ester-nukleotider og fremgangsmåder til fremstilling af samme | |
| DK3447051T3 (da) | Fremgangsmåde til fremstilling af tyrosinkinaseinhibitor og derivat deraf | |
| DK3294740T3 (da) | Hidtil ukendte sulfonimidoylpurinonforbindelser og derivater til behandling og profylakse af virusinfektion | |
| DK3740475T3 (da) | Fremgangsmåde til fremstilling af somatostatinmodulatorer | |
| DK3833665T3 (da) | Diazabicyclooctanoner som hæmmere af serin-beta-lactamaser | |
| DK3347342T3 (da) | Fremgangsmåde til fremstilling af biguanidin-salte og s-triaziner | |
| DK3522873T3 (da) | Sammensætninger og fremgangsmåder til behandlingen af xerostomi | |
| DK3452424T3 (da) | Fremgangsmåde og anlæg til fremstilling af cement | |
| DK3873894T3 (da) | Hidtil ukendt salt af en bcl-2-hæmmer, relateret krystallisk form, fremgangsmåde til fremstilling af samme og farmaceutiske sammensætninger, der indeholder samme | |
| DK3867194T3 (da) | Fremgangsmåde til fremstilling af syntesegas | |
| DK3725786T3 (da) | KRYSTALLINSK FORM OG SALTFORM AF TGF-ßRI INHIBITOR OG FORBEREDELSESMETODE FOR DETTE | |
| DK3442944T3 (da) | Fremgangsmåde til fremstillingen af 4-aminoindanderivater og relaterede aminoindanamider | |
| DK3760190T3 (da) | Tabletter af pregabalin med forlænget frigivelse, fremgangsmåde til fremstilling og fremgangsmåde til anvendelse deraf | |
| DK3408247T3 (da) | Fremgangsmåde til fremstilling af en gødningssammensætning og gødningssammensætning fremstillet derved |